Cite
Varona Pérez J, Rodriguez Chinesta JM. Riesgo de reactivación de la hepatitis B asociado al tratamiento con corticoides frente a SARS-CoV-2 (COVID-19). [Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids]. Rev Clin Esp (Barc). 2020;220(8):534-536doi: 10.1016/j.rce.2020.04.012.
Varona Pérez, J., & Rodriguez Chinesta, J. M. (2020). Riesgo de reactivación de la hepatitis B asociado al tratamiento con corticoides frente a SARS-CoV-2 (COVID-19). [Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids]. Revista clinica espanola, 220(8), 534-536. https://doi.org/10.1016/j.rce.2020.04.012
Varona Pérez, J, and Rodriguez Chinesta, J M. "Riesgo de reactivación de la hepatitis B asociado al tratamiento con corticoides frente a SARS-CoV-2 (COVID-19)." [Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids]. Revista clinica espanola vol. 220,8 (2020): 534-536. doi: https://doi.org/10.1016/j.rce.2020.04.012
Varona Pérez J, Rodriguez Chinesta JM. Riesgo de reactivación de la hepatitis B asociado al tratamiento con corticoides frente a SARS-CoV-2 (COVID-19). [Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids]. Rev Clin Esp (Barc). 2020 Nov;220(8):534-536. doi: 10.1016/j.rce.2020.04.012. Epub 2020 May 04. Spanish. PMID: 32372768; PMCID: PMC7198170.
Copy
Download .nbib